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Objective: Depolarizing potassium cardioplegia has been increasingly linked to left
ventricular dysfunction, arrhythmia, and microvascular damage. We tested a new
polarizing normokalemic cardioplegic solution employing adenosine and lidocaine
as the arresting, protecting, and preserving cardioprotective combination. Adenosine
hyperpolarizes the myocyte by A1 receptor activation, and lidocaine blocks the
sodium fast channels.
Methods: Isolated perfused rat hearts were switched from the working mode to the
Langendorff (nonworking) mode and arrested for 30 minutes, 2 hours, or 4 hours
with 200 mol/L adenosine and 500 mol/L lidocaine in Krebs-Henseleit buffer (10
mmol/L glucose, pH 7.7, at 37°C) or modified St Thomas’ Hospital solution no. 2,
both delivered at 70 mm Hg and 37°C (arrest temperature 22°C to 35°C).
Results: Adenosine and lidocaine hearts achieved faster mechanical arrest in (25 
2 seconds, n  23) compared with St Thomas’ Hospital solution hearts (70  5
seconds, n  24; P.001). After 30 minutes of arrest, both groups developed
comparable aortic flow at 5 minutes of reperfusion. After 2 and 4 hours of arrest
(cardioplegic solution delivered every 20 minutes for 2 minutes at 37°C), only 50%
(4 of 8) and 14% (1 of 7) of St Thomas’ Hospital solution hearts recovered aortic
flow, respectively. All adenosine and lidocaine hearts arrested for 2 hours (n  7)
and 4 hours (n 9) recovered 70% to 80% of their prearrest aortic flows. Similarly,
heart rate, systolic pressures, and rate-pressure products recovered to 85% to 100%
and coronary flows recovered to 70% to 80% of prearrest values. Coronary vascular
resistance during delivery of cardioplegic solution was significantly lower (P .05)
after 2 and 4 hours in hearts arrested with adenosine and lidocaine cardioplegic
solution compared with hearts arrested with St Thomas’ Hospital solution.
Conclusions: We conclude that adenosine and lidocaine polarizing cardioplegic
solution confers superior cardiac protection during arrest and recovery compared
with hyperkalemic depolarizing St Thomas’ Hospital cardioplegic solution.
Although 99% of all surgical cardioplegic solutions contain depo-larizing potassium, typically at concentrations above 15 mmol/L,1,2 an increasing number of studies have shown a link betweenexposure to high potassium and postcardioplegia ionic and met-abolic imbalances, myocardial stunning, arrhythmia, ischemicinjury, tissue edema, endothelial damage, free radical production,
and functional loss during reperfusion.2-4 Left ventricular dysfunction is thought to
arise from a decrease in adenosine triphosphate (ATP) content, an increase in
intracellular H concentration, and an increased sodium influx via the Na/H
exchanger, which in turn activates the Na/Ca2 exchanger (and possible Ca2
release from the sarcoplasmic reticulum), which in some cases may lead to a
potentially lethal rise in intracellular Na and Ca2, mitochondrial damage, apo-
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ptosis, and cell death.3,5-8 The increase in intracellular Na
and loss of K upon depolarization is believed to activate
the energy-dependent ion pumps, thereby increasing energy
demands during ischemia.
Alternative strategies to arrest the heart have been
sought.3,9 One strategy has been to use ATP-sensitive K
channel openers (pinacidil, nicorandil, or aprikalim), which
arrest the heart in diastole by polarizing the membrane and
thus minimizing metabolic perturbations, reducing trans-
membrane fluxes and the possibility of Na and Ca2
loading.2-4,9-11 Unfortunately, the potential use of K chan-
nel openers in normokalemic cardioplegia in the clinical
setting remains problematic. This is due in part to the
inconclusive results obtained in a variety of animal models
and because many K channel openers require a carrier
such as high concentrations of dimethylsulphoxide or etha-
nol.11
The aim of the present study is to quantify the efficacy of
adenosine and lidocaine (AL) as the arresting and protecting
combination in a normokalemic Krebs-Henseleit solution
(5.9 mmol/L K). Adenosine was chosen because of its K
channel-opening properties, which increase the outward K
current resulting in hyperpolarization via A1 receptor stim-
ulation and shortening of the action potential,12 and its
broad-spectrum cardioprotective actions.13-15 Lidocaine
was chosen largely because of its local anesthetic properties
(via blocking the Na fast channels and polarizing the
myocardial cell membrane and preventing activation of the
action potential)2,16 and for its antiarrhythmic effects.17 In
addition, adenosine and lidocaine have been shown sepa-
rately to protect against ischemia, by reducing Ca2 loading
in isolated myocardial and endothelial cells,16,18 to scav-
enge free radicals, and to possess vasodilatory and anti-
inflammatory properties.15,19,20 Hence, the combination of
adenosine and lidocaine would arrest the heart by prevent-
ing action potential generation and would protect the heart
from ischemia-reperfusion injury. Although adenosine
added to hyperkalemic blood cardioplegic solution21 and
Na fast-channel blockade has been investigated in a num-
ber of animal models,22,23 no study has investigated aden-
osine and lidocaine as the sole arresting combination. We
report that polarized arrest using normokalemic multidose
AL cardioplegia is far superior to depolarized arrest using
potassium-based St Thomas’ Hospital solution in the work-
ing rat heart model over 2 and 4 hours of arrest. We further
propose that the beneficial effects appear related to AL’s
ability to “clamp” the membrane potential near its resting
state and additional cardioprotective properties of each drug
alone and in combination.
Materials and Methods
Animals
Male Sprague-Dawley rats (323  6 g, n  47) were obtained
from Animal Resources Center (Canningvale, Wash) and James
Cook University’s breeding colony. Animals were fed ad libitum
and housed in a 12-hour light/dark cycle. On the day of the
experiment, rats were anesthetized with an intraperitoneal injection
of nembutal (sodium pentabarbitone; 60 mg/kg body weight) and
the hearts rapidly excised (details below).24 Rats were handled in
compliance with James Cook University Guidelines (ethics ap-
proval number A557) and with the Guide for Care and Use of
Laboratory Animals, published by the National Institutes of Health
(NIH publication 85, revised 1985). Adenosine (A9251 99%
purity) and all other chemicals were obtained from Sigma Chem-
ical Co (Castle Hill, New South Wales). Lidocaine hydrochloride
was purchased as a 2% solution (ilium) from Pharmaceutical
Supplies (Lyppard, Queensland).
Composition of Buffers and Arrest Solutions
Krebs-Henseleit perfusion buffer: Hearts were perfused in the
Langendorff and working mode with a modified Krebs-Hense-
leit buffer containing 10 mmol/L glucose, 117 mmol/L NaCl,
5.9 mmol/L KCl, 25 mmol/L NaHCO3, 1.2 mmol/L NaH2PO4,
1.12 mmol/L CaCl2 (free Ca2  1.07 mmol/L), 0.512 mmol/L
MgCl2 (free Mg2  0.5 mmol/L), pH 7.4 at 37°C.24 The
perfusion buffer was filtered with a 1-m membrane and then
bubbled vigorously with 95%O2/5%CO2 to achieve a PO2
greater than 600 mm Hg. The perfusion buffer was not recir-
culated.
AL arrest solution: Preliminary studies showed that 200 mol/L
adenosine plus 500 mol/L lidocaine in 10 mmol/L glucose
containing Krebs-Henseleit buffer (pH 7.7 at 37°C) gave opti-
mal arrest and recovery profiles in the rat model (data not
shown). The AL arrest solution was filtered with 0.2-m filters
and maintained at 37°C. The arrest solution was not actively
bubbled with 95% O2/5% CO2, hence the higher pH. The
average PO2 of the AL solution was 131 mm Hg and the PCO2
was 5 to 10 mm Hg.
Modified St Thomas’ Hospital solution No. 2: The composition of
modified St Thomas’ solution No. 2 was NaCl (110 mmol/L),
KCl (16 mmol/L), MgCl2 (16 mmol/L), CaCl2 (1.2 mmol/L),
NaHCO3 (25 mmol/L), and pH 7.8. The buffer was filtered with
0.2- filters and maintained at 37°C. The solution was not
actively bubbled with 95% O2/5% CO2 and had an average PO2
of 125 mm Hg and a PCO2 of 5 to 10 mm Hg). Glucose was not
included in St Thomas’ Hospital solution based on the findings
of Hearse and colleagues,2,25 who showed that glucose (with or
without insulin) may be deleterious when used as an additive.
Langendorff and working rat heart preparation: Hearts were rap-
idly removed from anesthetized rats and immediately placed in
ice-cold Krebs-Henseleit buffer. Excess tissue was removed,
and the heart was connected via the aorta to a standard Lange-
ndorff apparatus and perfused in a retrograde fashion with a
perfusion pressure of 90 cm H2O (68 mm Hg).26 After the
pulmonary veins and superior and inferior venae cavae had been
tied off to minimize leaks (1 mL/min), the pulmonary artery
was cannulated for collection of coronary venous effluent. The
preparation was then switched to the working mode and the
heart was not placed in a thermostat-regulated jacket so that
moderate decreases in temperature during arrest would mimic
the clinical drift in myocardial temperature. The preload was
preset at 10 cm H2O (7.6 mm Hg) and the afterload at 100 cm
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H2O (76 mm Hg). Hearts were stabilized for 30 minutes before
being converted back to the Langendorff nonworking mode and
before the arrest solution was administered (see below). Heart
rate, aortic pressure, coronary flow, aortic flow, and oxygen
consumption were measured before, during, and after arrest and
are summarized in Figure 1.
Aortic pressure was measured continuously with a pressure
transducer (UFI Instruments, Morro Bay, Calif) coupled to a
MacLab 2e (ADI Instruments, Richardson, Tex). Systolic and
diastolic pressures and heart rate were calculated from the pressure
trace using the MacLab software. Arterial and venous perfusate
PO2 and PCO2, pH, and ion concentrations (Ca2, Cl, and Na)
were measured with a Ciba-Corning 865 blood gas machine (Ciba-
Corning, Oberlin, Ohio). Coronary flow and aortic flow were
measured in volumetric cylinders. Stability studies show that aortic
flow decreases 5% to 10% per hour over a 2-hour perfusion period
at 37°C (unpublished observations) and similar to those published
by Taegtmeyer and colleagues.27 This loss was not taken into
account in adjusting aortic flow values during the postarrest reper-
fusion period (aortic flows reported in this study are those mea-
sured directly). The initial criteria for exclusion of working hearts
during the 30-minute equilibration period were a heart rate less
than 200 beats/min, a systolic pressure less than 100 mm Hg, and
coronary flow less than 10 mL/min. No pacing or cardiac massage
was used during the recovery phase in the working mode. The
surface temperature of the heart was measured with a Cole-Parmer
thermistor-thermometer (8402-20; Cole-Parmer Instrument Com-
pany, Vernon Hills, Ill) every 30 seconds throughout the 2 hours of
arrest. The thermistor probe was tucked under the left auricle, and
placement in the left heart chamber showed similar profiles as
subauricular placement.
Mode of Cardioplegic Delivery and Experimental
Protocol
A 50-mL induction dose of cardioplegic solution was administered
via the aorta at 37°C and at constant pressure of 70 mm Hg with
the heart in the Langendorff mode; at the completion of infusion,
the aorta was crossclamped with a plastic nontraumatic aortic clip.
For the 30-minute arrest protocol, the aorta was crossclamped for
15 minutes, after which it was released to deliver a 2-minute
infusion pulse of cardioplegic solution (15-20 mL) and the clamp
reapplied. A terminal cardioplegic infusion was repeated once
more at 32 minutes before the heart was unclamped and switched
to working mode at 34 minutes. For the 2- and 4-hour arrest
Figure 1. A, Experimental protocol for 30-minute, 2-hour, and 4-hour arrest in the rat heart model. B, Surface
temperature profile during arrest. After 30-minute equilibration, hearts were arrested with AL cardioplegic solution
or St Thomas’ Hospital solution and the aorta clamped. Every 18 minutes the clamp was released and cardioplegic
solution delivered for 2 minutes and the clamp reapplied (for 30-minute arrest, a 2-minute pulse was delivered at
15 minutes). Cardioplegic solution was delivered via the aorta at a perfusion head of 70 mm Hg and temperature
of 37°C. A 2-minute pulse was administered just before the heart was switched from Langendorff arrest to working
mode and recovery was monitored for up to 60 minutes.
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protocols, cardioplegic solution was replenished every 18 minutes
with a 2-minute infusion, after which the crossclamp was reap-
plied. After the terminal cardioplegic infusion, the heart was again
switched immediately to the working mode and reperfused with
oxygenated glucose-containing Krebs-Henseleit buffer (see Figure
1). The working heart was chosen because the ejecting model is
more representative of the natural flow through the heart, whereas
the standard Langendorff model receives retrograde flow through
the aorta and does no physical work. The Langendorff balloon
(nonworking) mode will give systolic and diastolic pressure indi-
ces, both of which are preload independent, but the working mode
allows one to observe cardiac output and flow under working
conditions and to calculate external work, and thereby efficiency.
One cannot readily calculate efficiency in the nonworking mode.
Estimation of Myocardial Cell Membrane Potential
Control (noninjured, nonischemic, prearrest) rat hearts were
freeze-clamped at liquid N2 temperatures in the working mode at
37°C (n  6). A separate group (n  6) was perfused in the
working mode and then switched to Langendorff and arrested
using St Thomas’ Hospital solution No. 2 at 37°C. A third separate
group (n  6) was perfused in the working mode and then
switched to the Langendorff mode and arrested using AL cardio-
plegia. A few minutes after the hearts were arrested, they were
freeze-clamped and the left ventricular tissue was ground at liquid
N2 temperatures in a mortar. The tissue was then transferred to
liquid N2-cooled tubes and kept at 80°C until use.
Cell membrane potential (VM in millivolts) was calculated
from the Nernstian distribution of K ion between the extracellular
and intracellular phases (Equation 1).
VM  EK 
RT
zKF
 ln
[K]out
[K]IN (1)
where R is the universal gas constant (8.31 J mol1 K1), F is
Faraday’s constant (96.49 KJ mol1 V1), T is absolute temper-
ature (311.15 K), z is the valence of potassium ion (1), and
[K]IN and [K]OUT are the intracellular and extracellular con-
centrations of K ion in mol/L, respectively.24 In brief, total tissue
potassium ([K]TOTAL) was measured on nitric acid–digested
freeze-clamped heart tissue (100 mg) by the methods described in
Masuda and colleagues.24 The [K]IN was calculated from the
following equation: [K]TOTAL  x [K]IN  y [K]OUT, where
x is the intracellular space and y is the extracellular space, respec-
tively. In the perfused working rat heart, the distribution of total
tissue water (see below) is 59% extracellular and 41% intracellu-
lar.24 It was assumed that [K]OUT was equal to the potassium
concentration in Krebs-Henseleit (5.9 mmol/L K), AL cardiople-
gic solution (5.9 mmol/L K), or St Thomas’ Hospital solution
No. 2 (16 mmol/L K).
Determination of Tissue Water and Hemodynamic
Calculations
Total tissue water (percent) was determined by the difference in
wet weight and dry weight divided by wet weight and multiplied
by 100. Powdered tissue from a number of hearts in control, during
different times of arrest without reperfusion and after arrest and
reperfusion, were dried to a constant weight at 85°C for up to 48
hours as described by Dobson and Cieslar.28
Coronary vascular resistance (CVR) in megadyne · seconds ·
cm5 was calculated during each 2-minute delivery of cardiople-
gic solution and calculated by dividing delivery pressure by flow
(volume/s) using Equation 2:
CVR 
1333 mm Hg
(mL/s)  10
6 (2)
where 1 mm Hg  1333 dynes cm2 and 106 is a conversion
factor from dynes to megadynes.
Cardiac oxygen consumption, MVO2 (mole O2/min/g dry
weight heart), was calculated from Equation 3.
MVO2 
(PaO2)  PvO2)
(Bp  Vp) 
O2
22.40
coronary flow
g dry wt  1000

mm Hg
mm Hg
mL/mL
mL/mmol
mL/min
g dry wt 1000 (3)
where PaO2 and PvO2 are the partial pressures of oxygen
(mm Hg) in the arterial and venous perfusion lines. Bp is the
barometric pressure (760 mm Hg) and Vp is the water vapor
pressure at 37°C  47.1 mm Hg. The molar volume for
oxygen at standard temperature and pressure (STP) was
22.40 mL/millimole. O2 is the Bunsen solubility coeffi-
cient defined as that volume of oxygen gas dissolved in 1
mL of solution at a specified temperature reduced to STP
(0°C, 760 mm Hg).29 The O2 at 37°C for human plasma is
0.024 mL/mL.30 Coronary flow (coronary venous effluent)
is measured in milliliters per minute and heart weight is
expressed as grams dry weight.
External cardiac work or power output (J/min/g dry weight heart)

(aortic coronary flow) ( 106)
heart dry weight 
average systolic pressure
1

101,325
760

ml/min • m3/mL
g dry wt 
mm Hg

Nm2
mm Hg
where 106 is required to convert 1 mL into cubic meters and
1 atm  760 mm Hg  101,325 Newton meters2 (Nm2).
Statistics
All results are expressed as mean  standard error of the mean
(SEM). Statistics were performed separately for each of the 30-
minute, 2-hour, and 4-hour protocols. Two-way analysis of vari-
ance (ANOVA) for repeated measures was used to compare dis-
crete variables (eg, coronary resistance, aortic flow, systolic
pressures, oxygen consumption, external work) over multiple time
points between the AL and St Thomas’ Hospital solution treatment
groups. The alpha level of significance for all experiments was set
at P  .05.
Results
Heart Membrane Potential
The resting membrane potential for control isolated working
rat hearts was 83  2 mV (n  6), which is in agreement
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with other published values for rat heart24 and isolated
guinea pig heart31 (Table 1). The membrane potential for rat
hearts arrested with St Thomas’ Hospital solution No. 2 was
48  3 mV (n  6), similar to published values measured
with microelectrodes32 and to values in hearts arrested with
16 mmol/L KCl alone for both rat22 and guinea pig31 (Table
1). The membrane potential calculated for rat hearts arrested
with AL cardioplegic solution was 83  2 mV (n  6).
Control Perfusion, Times to Arrest, and Arrest
Temperature
During the prearrest (or control period) there was no sig-
nificant difference in functional parameters between the 2
groups tested in the 30-minute, 2-hour, and 4-hour arrest
series (Tables 2, 3, and 4). Hearts receiving AL cardioplegic
solution achieved electrical and mechanical arrest in 25 2
seconds (n  23) compared with 70  5 seconds (n  24)
for St Thomas’ Hospital solution hearts (Figure 2). After
delivery of the 50-mL induction volume of cardioplegic
solution, 9 of 23 AL hearts experienced an average of 1.3
0.2 escape beats followed by total arrest. St Thomas’ Hos-
pital solution hearts arrested progressively (based on the
developed aortic pressure) over a longer period of time
without appearance of escape beats (Figure 2).
A representative profile of the myocardial surface tem-
perature for either AL hearts or St Thomas’ Hospital solu-
tion hearts is shown in Figure 1, B. During the control and
1-hour reperfusion periods, heart temperature was 37°C, but
during the arrest period myocardial temperature cycled be-
tween 35°C and 22°C. This cycling occurred because the
heart was not placed in a temperature-controlled jacket and
the peak temperatures correspond to the 2-minute delivery
of cardioplegic solution at 37°C and the valleys correspond
to the end of the 18-minute intervening ischemic period.
The average heart temperature over 2 hours of arrest was
28°C to 30°C and was not different between AL and St
Thomas’ Hospital solution hearts (Figure 1, B). However,
we acknowledge that normothermic delivery of St Thomas’
Hospital cardioplegic solution differs from its current clin-
ical use, but this strategy allowed us to test the limits of AL
at higher temperatures, which are becoming the preferred
practice in cardiac surgery.
Cardioplegia Delivery Volumes, Coronary Vascular
Resistance, and O2 Consumption during 2-Minute Off-
Clamp
The total volume of cardioplegic solution delivered over 4
hours to AL hearts was 273 mL and 201 mL for St Thomas’
Hospital solution hearts. For example, at 240 minutes of
arrest, 17 mL of cardioplegic solution was delivered to AL
hearts and 7.3 mL to St Thomas’ Hospital solution hearts.
CVR during the infusions of cardioplegic solution in the 2-
and 4-hour arrest series is shown in Figure 3, A. After the
terminal delivery in the 2-hour arrest series, AL hearts had
significantly lower CVR than the St Thomas’ Hospital so-
lution hearts (P  .05), which is consistent with the greater
volumes of cardioplegic solution.
Oxygen consumption during infusions of cardioplegic
solution was significantly greater in the AL group than in
the St Thomas’ Hospital solution group in the 2- and 4-hour
arrest series (Figure 3, B). The higher oxygen consumption
(1.5-3 times baseline) was due to both an increase in per-
fusate aortic–coronary venous PO2 difference (83 1.6 mm
Hg for AL hearts and 62  1.9 mm Hg for St Thomas’
Hospital solution hearts in the 4-hour arrest series) and
greater coronary arterial flows in AL hearts. At present, it is
difficult to determine whether vasodilation is the primary
cause of the differences in oxygen consumption between the
2 groups, although it is noteworthy that vasodilation by
itself does not increase oxygen consumption unless there is
a flow limitation. During infusions of cardioplegic solution,
oxygen consumption in AL and St Thomas’ Hospital solu-
tion hearts decreased to 10% and 5% of their prearrest
baseline, respectively.
Functional Profiles during Recovery
Hearts arrested for 30 minutes with AL cardioplegic solu-
tion or modified St Thomas’ Hospital cardioplegic solution
TABLE 1. Estimates of the membrane potential (in milli-
volts) in the isolated rat heart before and during arrest by
adenosine and lidocaine (AL) cardioplegia (5.9 mmol/L K),
hyperkalemic St Thomas’ Hospital solution no. 2 (16 mmol/L
K), or 16 mmol/L KCl at 37°C
Treatment n
Cell
membrane
potential
(mV)*
Published
values (mV) Reference
Normal prearrest
controls
6 83 2 84 2‡ Masuda and
colleagues24
84 1§,¶ Kleber31
St Thomas’ Hospital
solution No. 2
6 48 3 50§ Chambers32
16 mmol/L KCl
(8°C)
7 50§ Snabaitis and
colleagues22
16 mmol/L KCl 6 49.5 1§,¶ Kleber31
AL cardioplegia† 6 83 2 This study
All values are mean  SEM.
*This study. The membrane potential was calculated from the Nernstian
distribution of K ion between intracellular and extracellular phases of left
ventricle (see Materials and Methods).
†Adenosine (200 mol/L) and lidocaine (500 mol/L) arresting combination
was in 10 mmol/L glucose-containing Krebs-Henseleit solution pH 7.4 (see
Materials and Methods).
‡Healthy (noninjured) prearrest perfused isolated rat hearts in the working
mode.
§Measured using 3 mmol/L KCl microelectrodes.
¶Isolated perfused guinea pig heart.
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spontaneously recovered electrical activity in 2 minutes,
and by 5 minutes all hearts recovered about 60% of prear-
rest aortic flow (Figure 4, A). Although both groups contin-
ued to increase aortic flows in the first 15 minutes of
reperfusion, St Thomas’ Hospital solution hearts began to
decrease flow after 15 minutes and averaged 65% of base-
line at 30 minutes of reperfusion. In contrast, AL hearts
after 30 minutes of reperfusion generated significantly
greater aortic flows than St Thomas’ Hospital solution
hearts (87% of prearrest values, P  .05). At 60 minutes,
aortic flow in St Thomas’ Hospital solution hearts decreased
to about 50% prearrest values while AL hearts decreased
to 70% of baseline values without group differences (Figure
4, A). Peak systolic pressure and external cardiac work also
recovered quickly in the first 5 minutes, with higher values
in AL hearts, but the differences were not significant (Figure
4, B and C). Similarly, there were no significant differences
in recovery of coronary flow, heart rate, rate-pressure prod-
uct, or oxygen consumption between the 2 cardioplegia
groups in the 30-minute arrest series (Table 2).
In contrast to the 30-minute arrest series, hearts arrested
for 2 and 4 hours displayed very different recovery profiles.
St Thomas’ Hospital solution hearts showed significantly
lower functional recoveries during and at the end of reper-
fusion. Mean aortic flow at the end of reperfusion was
approximately 22% and 5% to 10% of prearrest values after
2 and 4 hours of arrest, respectively (Figure 4, A). Similarly,
systolic pressures at the end of reperfusion were 70 and 30
mm Hg for 2- and 4-hour arrest, respectively (Figure 4, B),
and external work averaged 13 and 4.0 J min1 g1 dry
weight, respectively (Figure 4, C). For the 2-hour St
Thomas’ Hospital solution group, heart rate, coronary flow,
rate-pressure product, and oxygen consumption recovered
to 40% to 50% of their prearrest values after reperfusion
(Table 3). After 60 minutes of reperfusion, the 4-hour St
Thomas’ Hospital solution group could generate only 32%
of the prearrest heart rate, 23% of systolic pressure, 5% of
aortic flow, 16% of coronary flow, 14% of rate-pressure
product, and 6% of the prearrest external cardiac work
(Figure 4, Table 4). In direct contrast, rat hearts arrested
TABLE 2. Functional parameters of isolated working rat hearts during prearrest and reperfusion following 30-minute arrest
with adenosine-lidocaine (AL) cardioplegia or modified St Thomas’ Hospital solution (St T)
30-minute arrest
protocol Treatment n
Heart rate
(beats/min)
Aortic flow
(mL/min)
Coronary flow
(mL/min)
Rate pressure
product (mm
Hg/min)
O2 consumption
(mol/min/g dry
weight)*
5-min prearrest AL 7 245 11 34.3 3.6 21.6 2.0 31504 1650 47.3 4.8
St T 9 276 12 32.8 2.1 19.4 1.6 34090 1110 44.7 4.2
15-min recovery AL 7 225 19 29.2 3.2 17.1 1.8 28228 2015 52.0 11
St T 9 256 10 24.8 2.4 17.0 1.6 31131 1267 33.2 6.7
30-min recovery AL 7 237 14 29.6 2.8† 16.5 1.5 29403 1231 44.7 4.3
St T 9 255 12 22.3 3.3 17.1 1.2 31154 1464 40.2 4.0
60-min recovery AL 7 245 11 22.4 3.5 15.5 0.5 29269 1239 48.2 6.2
St T 9 258 14 17.0 3.1 15.4 1.2 30392 1727 39.1 2.8
*To convert from mol/min/g dry weight to wet weight divide by 7.46 for both prearrest groups and by 9.26 (AL hearts) and 7.41 (St Thomas’ Hospital solution
hearts) in recovery (see text for details).
†P  .05 signifies significance between AL and St Thomas’ Hospital solution groups.
TABLE 3. Functional parameters of isolated working rat hearts during prearrest and reperfusion following 2-hour arrest
with adenosine-lidocaine (AL) cardioplegia or modified St Thomas’ Hospital solution (St T)
2-hour arrest
protocol Treatment n
Heart rate
(beats/min)
Aortic flow
(mL/min)
Coronary flow
(mL/min)
Rate pressure
product (mm
Hg/min)
O2 consumption
(mol/min/g dry
weight)*
5-min prearrest AL 7 259 20 33.2 2.7 17.1 1.8 30998 2046 45.3 4.30
St T 8 259 13 34.5 2.1 18.0 1.3 31329 1720 46.1 2.60
15-min recovery AL 7 215 24 17.0 3.6 15.3 1.4 24934 2506 53.6 7.2
St T 8 108 32† 5.9 3.8 7.3 2.9† 9514 3737† 16.4 6.6
30-min recovery AL 7 248 22 25.5 2.3 15.4 1.6 28722 2149 51.6 5.6
St T 8 148 47† 9.4 7.0† 8.93 4.6 12498 6863† 18.9 7.5
60-min recovery AL 7 245 26 24.6 2.7 13.8 1.7 27958 2457 49.8 6.5
St T 8 147 45† 7.7 5.9† 8.35 4.4 11808 6533† 18.8 7.8
*To convert from mol/min/g dry weight to wet weight divide by 7.46 for both prearrest groups and by 9.26 (AL hearts) and 7.41 (St Thomas’ Hospital solution
hearts) in recovery (see text for details).
†Significance between treatment groups P  .05.
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with AL cardioplegic solution for 2 and 4 hours recovered
up to 77% and 70% of their prearrest aortic flows after
reperfusion, respectively (Figure 4, A). AL hearts arrested
for 2 and 4 hours also recovered systolic pressures, external
cardiac work, oxygen consumption rates, and rate-pressure
products to 85% to 100% of their prearrest values (Figure 4,
B and C, and Tables 3 and 4).
Total tissue water content measured in separate sham
control rat hearts exposed to the prearrest working mode
averaged 86.6% 1.1% (n 4), values consistent with our
earlier studies.24 Total tissue water content in the St
Thomas’ Hospital solution and AL hearts measured in sep-
arate hearts at different times during the 2- and 4-hour arrest
periods (without reperfusion) averaged 87%  0.8% (n 
8) and 88.7%  0.3% (n  14), respectively (P  .05).
However, there were no significant differences found within
each cardioplegia group during the 30-minute, 2-hour, or
4-hour arrest protocols. Separate measurements on different
hearts were also made after reperfusion. The average values
during 60-minute reperfusion were 86.5  0.6% (n  14)
and 89.2 0.3% (n 20) for St Thomas’ Hospital solution
and AL hearts, respectively, after 4-hour arrest. As during
arrest without reperfusion, AL hearts had significantly
higher postreperfusion water contents than St Thomas’ Hos-
pital solution hearts (P  .05); however, there was no
correlation between tissue water gain and the differences in
functional recovery.
In summary, only 50% of St Thomas’ Hospital solution
hearts (4/8) arrested for 2 hours could develop aortic flow
against an afterload of 100 cm H2O, and that percentage
Figure 2. A representative record of time to electromechanical arrest using AL cardioplegic solution and modified
St Thomas’ Hospital solution No. 2. The average arrest time for AL hearts was 25  2 seconds (n  23) and St
Thomas’ Hospital solution hearts 70  5 seconds (n  24). In the St Thomas’ Hospital solution hearts a few beats
just before arrest were common in this group (shown here 60 seconds), but they were not normally as strong as
indicated here.
Cardiopulmonary Support and Physiology Dobson and Jones
800 The Journal of Thoracic and Cardiovascular Surgery ● March 2004
CSP
decreased to 17% (1 of 7) in the 4-hour arrest series (Figure
5). In sharp contrast, 100% of hearts arrested with AL
cardioplegic solution recovered aortic flow against 100 cm
H2O after 2 hours (n  7) and 4 hours (n  9) (Figure 5).
Discussion
Our study shows that the arresting combination of 200
mol/L adenosine and 500 mol/L lidocaine (AL) in nor-
mokalemic Krebs-Henseleit buffer at pH 7.4 and 37°C is far
superior to hyperkalemic St Thomas Hospital solution dur-
ing prolonged (2 or 4 hours) arrest. Rat hearts arrested with
multidose AL cardioplegiac soltuion showed: (1) signifi-
cantly faster electromechanical arrest times (25 vs 70 sec-
onds, P  .05); (2) lower coronary vascular resistance
during cardioplegic infusions (Figure 3); (3) superior recov-
ery of left ventricular function after prolonged arrest (Figure
4, Tables 3 and 4); and (4) a polarized membrane potential
of 83 mV (Table 1). The agreement between the mem-
brane potential estimated from the steady-state extracellular
and intracellular phase distribution of K ions, and micro-
electrode techniques shows that the heart membrane poten-
tial is predominately a potassium equilibrium potential
where the sum of the electrical and chemical concentration
forces on the ion is zero (	GK  0).24 To our knowledge,
AL has not been used as the sole arresting and cardiopro-
tective combination in either normokalemic cardioplegic
solutions or longer-term normokalemic preservation solu-
tions.
Although the mechanisms of cardioprotection of AL
cardioplegia were not investigated in the present study,
possible reasons for AL’s superiority over modified St
Thomas’ Hospital solution may include the following.
1. AL exhibits better preservation of ATP and phospho-
creatine, glycogen stores, and maintenance of a high
cytosolic phosphorylation ([ATP]/[ADP] [Pi]) ratio,
	G'ATP, and low redox (lactate/pyruvate) ratios during
arrest, ischemia, and reperfusion.
2. Adenosine’s ability to activate A1 receptor subtype
and slow the sinoatrial nodal pacemaker rate (negative
chronotropy), delay atrioventricular (AV) nodal im-
pulse conduction (negative dromotropy), and reduce
atrial contractility (negative inotropy) will contribute
to arresting the heart.33 Adenosine A1 receptors (and
possibly A3 receptors) are also known to confer pro-
tection via inhibitory G protein-coupled pathways,
which in some instances have been linked to the
opening of sarcolemmal ATP-sensitive K chan-
nels.19,34-36 More recently, adenosine A1 receptor ac-
tivation has been linked to new cardioprotective tar-
gets including the mitochondria36-38 and sarcoplasmic
reticulum.39 A1 receptor activation is also implicated
in adenosine’s ability to blunt the stimulatory effects
of catecholamines and inhibition of norepinephrine
release from nerve terminals.15
3. A third factor for the superiority of AL cardioplegic
solution is lidocaine’s ability to close Na-fast chan-
nels in the atria and ventricles and thereby inhibit the
phase 0 upstroke of the action potential and subse-
quent action potentials.2 Although the precise mecha-
nisms of lidocaine’s action with the ion-conducting
pore are not fully known,40 the Na channel blocker
effectively “clamps” the cell membrane near or at its
resting membrane potential and, as fewer ion channels
or pumps are activated at polarized potentials, the drug
may reduce energy-dependent activity and thereby
have energy-sparing effects. In addition, lidocaine
may act alongside adenosine to further reduce Na
and Ca2 loading.6,16,18 The possibility also exists that
lidocaine in combination with adenosine may exert
additional arresting and cardioprotective actions
TABLE 4. Functional parameters of isolated working rat hearts during prearrest and reperfusion following 4-hour arrest
with adenosine-lidocaine (AL) cardioplegia or modified St Thomas’ Hospital solution (St T)
4-hour arrest
protocol Treatment n
Heart rate
(bpm)
Aortic flow
(mL/min)
Coronary flow
(mL/min)
Rate pressure
product (mm Hg/
min)
O2 consumption
(mol/min/g dry weight)*
5-minute prearrest AL 9 275 13 36.5 1.7 16.28 1.0 32338 1084 50.3 3.4
St T 7 259 13 41.2 4.2 16.03 1.3 31508 1672 57.2 1.8
15-minute recovery AL 9 229 16 19.8 3.6 13.9 1.5 25327 1555 55.0 6.4
St T 7 67 28† 2.7‡ 2.3† 3815 3040† 5.7 5.1†
30-minute recovery AL 9 239 19 24.6 2.9 11.5 1.0 26684 1669 45.7 4.1
St T 7 79 26† 2.4† 2.9‡ 4137 3170† 6.1 5.5†
60-minute recovery AL 9 249 17 25.6 3.3 11.4 1.3 27569 1577 44.6 4.8
St T 7 83 30† 2.1† 2.6† 4359 3527† 7.1 6.5†
*To convert from mol/min/g dry weight to wet weight divide by 7.46 for both prearrest groups and by 9.26 (AL hearts) and 7.41 (St Thomas’ Hospital solution
hearts) in recovery (see text for details).
†Significance between treatment groups P  .001.
‡Significance between treatment groups P  .05.
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through some unknown A1 receptor, ATP-sensitive
potassium channel, and/or Na fast channel interac-
tion(s).
4. Superior arrest and protection may also relate to the
coronary vasodilatory properties of adenosine and li-
docaine, resulting in the reduced coronary vascular
resistance and greater delivery of cardioplegic solu-
tion (Figure 3). The lower coronary resistance in AL
hearts was not due to reduced tissue edema (88.7%)
and its extravascular compression, nor was St
Thomas’ Hospital solution’s higher resistance and
poor performance due to increased edema (87%). It is
noteworthy that total tissue water in crystalloid per-
fused rat hearts range from 85% to 88%24 and is
Figure 3. A, CVR during 2- and 4-hour arrest. B, Oxygen consumption during 2- and 4-hour arrest. CVR was
calculated during the 2-minute cardioplegia delivery times every 18 minutes (see Figure 1). Values are mean 
SEM and asterisk shows significance between the 2 cardioplegia groups from repeated-measures ANOVA (P <
.05). All statistical tests for the 2- and 4-hour AL and St Thomas’ Hospital solution arrest protocols were performed
separately. For clarity, only the 4-hour arrest data are presented for oxygen consumption and arrest time; no
significant differences in the first 2 hours were found between the 2- and 4-hour arrest protocols.
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Figure 4. Aortic flow (A), systolic pressure (B), and external cardiac work (C) during the reperfusion period after
30-minute, 2-hour, and 4-hour arrest with AL cardioplegic solution and modified St Thomas’ Hospital solution no.
2. Aortic flow is expressed as percentage of control at 5 minutes before arrest. Values are mean  SEM and
asterisk shows significance between the 2 cardioplegia groups at different arrest times (P < .05). For St Thomas’
Hospital solution hearts, only 50% (4/8) and 14% (1/7) recovered aortic flow after 2- and 4-hour arrest, respectively.
The systolic pressures 5 minutes before arrest in the AL and St Thomas’ Hospital solution hearts (in parentheses)
for the 30-minute, 2-hour, and 4-hour groups were 128  3 mm Hg (124  1.3 mm Hg), 120  2 mm Hg (121  3 mm
Hg), and 118  3.5 mm Hg (122  2.4 mm Hg), respectively. The hydraulic work 5 minutes before arrest in the AL
and St Thomas’ Hospital solution hearts (in parentheses) for the 30-minute, 2-hour, and 4-hour groups were 42 
5 J min1 g1 dry weight (43  7 J min1 g1 dry weight), 41  2 J min1 g1 dry weight (38  3 J min1 g1
dry weight), and 44  2 J min1 g1 dry weight (45  2 J min1 g1 dry weight) J min1 g1 dry weight,
respectively.
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significantly greater than in situ rat hearts (79%).28
Perfused hearts undergo major redistributions of tissue
water with the extracellular space increasing about 2
times the in situ value.24,28 Therefore, hearts treated
with either AL or St Thomas’ Hospital solution ap-
peared to accumulate tissue water. Further studies are
required to investigate the effect of AL cardioplegic
soltuion on coronary blood flow and the distribution of
water in the interstitial, extracellular, and intracellular
compartments.
5. AL’s superior protection may be associated with other
compositional differences to St Thomas’ Hospital car-
dioplegic solution. AL cardioplegic soltuion contains
a “physiologic” nondepolarizing concentration of po-
tassium similar to that concentration found in blood.
Concentrations of potassium above 15 mmol/L have
been linked to left ventricular dysfunction, which is
more pronounced at higher temperatures.3,6-8,41 In
1991 Mankad and colleagues42 also reported that high
potassium in St Thomas’ Hospital solution or
Bretschneider solution resulted in endothelial damage,
and this deleterious effect was concentration-depen-
dent. AL cardioplegic soltuion also has a lower “phys-
iologic” concentration of magnesium (0.5 mmol/L),
and although higher concentrations have been shown
to be cardioprotective in hyperkalemic solutions,2 the
lower concentration in AL solution did not appear to
compromise function. In addition, superior protection
and preservation of AL cardioplegia may be due to the
presence of exogenous glucose (10 mmol/L). As in-
dicated in Materials and Methods, we omitted glucose
from the St Thomas’ Hospital solution because Hearse
and colleagues2,25 showed that its presence was detri-
mental to postarrest functional recovery, a concept
that is reflected in the absence of glucose from com-
mercially available Plegisol solution (Abbott Labora-
tories, North Chicago, Ill). However, preliminary
studies show that under our experimental conditions
the presence of 10 mmol/L glucose in St Thomas’
Hospital solution did modestly improve aortic flow
after 4 hours of arrest from 2 to 8 mL/min (n  4)
at 30- to 60-minute reperfusion (unpublished observa-
tions). In addition, the presence or absence of glucose
did not alter the postcardioplegia recovery of function
in the St Thomas’ Hospital solution group relative to
the AL group.
In conclusion, the polarizing combination of adenosine
and lidocaine unifies the concepts of efficient cardiac arrest
with potent myocardial protection from ischemic-reperfu-
sion injury that are the attributes of the “ideal” cardioplegic
solution, which is not embraced with the current potassium-
and hypothermia-based cardioplegia strategies. The thera-
peutic efficacy of normothermic AL blood cardioplegia,
including adenosine’s stability, redosing requirements, and
Figure 5. Percentage of hearts with aortic flow after 0.5, 2, and 4 hours of multidose AL and modified St Thomas’
Hospital solution cardioplegia. Shaded areas depict AL-arrested hearts and unshaded areas are St Thomas’
Hospital solution hearts. Failure to survive was defined as the inability of the heart to develop aortic flow against
an afterload of 100 cm H2O (see text).
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hemodynamic effects, is currently being investigated in
larger animal models undergoing cardiopulmonary bypass.
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